Journal of Neuroscience and Behavioral Health
Subscribe to JNBH
Full Name*
Email Address*

Article Number - 353949A65481


Vol.9(1), pp. 10-15 , July 2017
https://doi.org/10.5897/JNBH2014.0120
ISSN: 2141-2286


 Total Views: 0
 Downloaded: 0

Full Length Research Paper

Neuroprotective effect of Silibinin against middle cerebral artery occlusion induced focal cerebral ischemia and brain injury in Wistar rats



Shivani Chauhan
  • Shivani Chauhan
  • Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, UP, India.
  • Google Scholar
Lubhan Singh
  • Lubhan Singh
  • Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, UP, India.
  • Google Scholar
Kedarinath Talishetty
  • Kedarinath Talishetty
  • Department of Pharmacology, Krupanidhi College of Pharmacy, Bangalore, Karnataka, India.
  • Google Scholar
Vipul Kumar
  • Vipul Kumar
  • Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, UP, India.
  • Google Scholar







 Received: 23 May 2015  Accepted: 27 July 2015  Published: 31 July 2017

Copyright © 2017 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Silibinin (Silybin) as an active constituent derived from milk thistle (Silybum marianum) has been shown to have antioxidant and anti-apoptotic properties. In traditional system of medicine, Silybum marianum has been used for treating various kinds of ailments including liver disease and cancer; however, clinical studies are largely heterogeneous and contradictory. The present study was designed to investigate whether Silibinin protects neuronal injury against middle cerebral artery occlusion induced oxidative stress associated damages in focal cerebral ischemia in Wistar rats. Rats weighing 250 to 300 g were pretreated with Silibinin 100 mg/kg and 200 mg/kg body weight, suspended in 0.5% of gum acacia) once daily for seven days. On 8th day, they underwent for middle cerebral artery 2 h suture occlusion by nylon suture. After 120 min of middle cerebral artery occlusion (MCAO) and 22 h of reperfusion, behavioral tests were assessed in terms of neurological deficits. Animals were sacrificed and infarct volume in Triphenyltetrazolium chloride (TTC) stained brain sections was measured. Further, various oxidative biomarkers were estimated in brain homogenates of rats. Pretreatment with Silibinin at doses of 100 and 200 mg/kg significantly improved the neurobehavioural alterations and reduced the infarct volume whereas 200 mg/kg Silibinin significantly increases the Glutathione (GSH) level and the others parameters with respect to control values. These results clearly indicate the neuroprotective effect of Silibinin against middle cerebral artery occlusion associated with oxidative damage induced brain injury due to its antioxidant and anti-apoptotic property.
 
Key words: Neuroprotective, MCAO, Silibinin, oxidative stress, infarct volume, cerebral ischemia.
 

Aebi H (1984). Catalase in-vitro. Methods of Enzymology, Academic Press 113:121-126.
Crossref

 

Bondy SC (1995). The relation of oxidative stress and hyperexcitation to neurological disease, Proc. Soc. Exp. Biol. Med. 208:337-345.
Crossref

 
 

Carmichael ST (2005). Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2:396-409.
Crossref

 
 

Chan PH (2001). Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21:2-14.
Crossref

 
 

Courtois M, Maupoil V, Fantini E, Durot I, Javouhey-Donzel A, Athias P (1998). Correlation between direct ESR spectroscopic measurements and electromechanical and biochemical assessments of exogenous free radical injury in isolated rat cardiac myocytes. Free Radic. Biol. Med. 24:121-131.
Crossref

 
 

Dringen R, Gutterer JM, Hirrlinger J (2000). Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267:4912-4916.
Crossref

 
 

Durukan A, Tatlisumak T (2007). Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87:179–197.
Crossref

 
 

Ellman GL (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:70-77.
Crossref

 
 

Green LC, Wagner DA, Glogowski J, Skipper L, Wishnok JS, Tannenbaum SR (1982). Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
Crossref

 
 

Halliwell B (1992). Reactive oxygen species and the central nervous system. J. Neurochem. 59 (5):1609-1623.
Crossref

 
 

Kakkar P, Das B, Viswanathan PN (1984). A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21:130-132.

 
 

Koizumi J, Yoshida Y, Nakazawa T, Ooneda G (1986). Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke 8:1-8.
Crossref

 
 

Kulkarni SK (1999). Hand Book of Experimental Pharmacology. Vallabh Prakashan, New Delhi.

 
 

Kuroda S, BK Siesjo (1997). Reperfusion damage following focal ischemia: Pathophysiology and therapeutic windows. Clin. Neurosci. 4:199-212.

 
 

Lipton P (1999). Ischemic cell death in brain neurons. Physiol. Rev. 79:1431-1568.

 
 

Longa EZ, Weinstein PR, Carlson S, Cummins R (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
Crossref

 
 

Lowry OH, Rosebrough NJ, Far AL, Randall RJ (1951). Protein measurement with folin-phenol reagent. J. Biol. Chem. 193:265-275.

 
 

Lu P, Mamiya T, Mouri A, Nagai T (2009). Silibinin prevents amyloid b peptide-induced memory impairment and oxidative stress in mice. Br. J. Pharmacol. 157:1270-1277.
Crossref

 
 

Shukla PK, Khanna VK, Ali MM, Maurya R, Khan MY, Srimal RC (2006). Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat. Hum. Exp. Toxicol. 25:187-194.
Crossref

 
 

Takemura G, Onodera T, Millard RW, Ashraf M (1993). Demonstration of hydroxyl radical and its role in hydrogen peroxide-induced myocardial injury: hydroxyl radical dependent and independent mechanisms. Free Radic. Biol. Med. 15:13-25.
Crossref

 
 

Tota SK, Kamat PK, Shukla R (2011). Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of Silibinin against streptozotocin induced memory impairment. Behav. Brain Res. 221:207-15.
Crossref

 
 

Van derWorp HB, van Gijn J (2007). Clinical practice. Acute ischemic stroke. New Engl. J. Med. 357:572-579.
Crossref

 
 

Yagi K (1982). Assay for serum lipid peroxide level and its clinical significance. In: Yagi, K. (Ed.), Lipid Peroxides in Biology and Medicine. Academic Press, New York, P 232.
Crossref

 
 

Zemke D, Smith JL, Reeves MJ, Majid A (2004). Ischemia and ischemic tolerance in the brain: An overview, Neurotoxicology 25:895-904.
Crossref

 
 

Zhu YZ, Huang SH, Tan BK, Sun J, Whiteman M, Zhu YC (2004). Antioxidants in Chinese herbal medicines: A biochemical perspective. Nat. Prod. Rep. 21:478-489.
Crossref

 

 


APA Chauhan, S., Singh, L., Talishetty, K., & Kumar, V. (2017). Neuroprotective effect of Silibinin against middle cerebral artery occlusion induced focal cerebral ischemia and brain injury in Wistar rats. Journal of Neuroscience and Behavioral Health, 9(1), 10-15.
Chicago Shivani Chauhan, Lubhan Singh, Kedarinath Talishetty and Vipul Kumar. "Neuroprotective effect of Silibinin against middle cerebral artery occlusion induced focal cerebral ischemia and brain injury in Wistar rats." Journal of Neuroscience and Behavioral Health 9, no. 1 (2017): 10-15.
MLA Shivani Chauhan, et al. "Neuroprotective effect of Silibinin against middle cerebral artery occlusion induced focal cerebral ischemia and brain injury in Wistar rats." Journal of Neuroscience and Behavioral Health 9.1 (2017): 10-15.
   
DOI https://doi.org/10.5897/JNBH2014.0120
URL http://academicjournals.org/journal/JNBH/article-abstract/353949A65481

Subscription Form